Sabuntawar Duniya ta Mpox da Bincike Mai Ci gaba

1. Sabuntawar Cututtuka ta Duniya na Mpox (kamar yadda aka yi a watan Maris na 2026)

Mpox, wanda kwayar cutar Monkeypox (MPXV) ke haifarwa, ya ci gaba da zama abin damuwa ga lafiyar jama'a a duniya duk da cewa Hukumar Lafiya ta Duniya ta ayyana shi a matsayin Gaggawar Kula da Lafiyar Jama'a ta Duniya (PHEIC). Ci gaba da yaɗuwa a yankuna da dama yana nuna buƙatarci gaba da sa ido da kuma ci gaba da iyawar ganewar asali.

Tun bayan barkewar cutar a duk faɗin duniya a shekarar 2022, an samu rahoton kusan mutane 128,000 da aka tabbatar da kamuwa da cutar da kuma mace-mace 281 a ƙasashe sama da 130 [1]. A shekarar 2025 kaɗai, ƙasashe 96 ne suka tabbatar da kamuwa da cutar 50,751 da kuma mace-mace 206, inda sama da kashi 90% na waɗanda suka kamu da cutar suka kamu da cutar a Afirka. Abin lura shi ne, Jamhuriyar Dimokuraɗiyyar Kongo, Saliyo, da Uganda sun kai kimanin mutane 32,000 da suka kamu da cutar, wanda hakan ya nuna irin wannan nauyi da ya yi yawa a yankunan da cutar ta fi kamari [1].

Duk manyan ƙwayoyin cuta na MPXV (Ia, Ib, da II) suna ci gaba da yaɗuwa. Bayyanar cutar Clade Ib da yaɗuwarta a ƙasashen duniya—har da gano cutar a Jamhuriyar Czech, Isra'ila, Madagascar, da Nepal—da kuma bayanan da aka tattara game da yaɗuwar cutar a cikin al'umma a Faransa, Italiya, da Spain, ya nuna.canjin yanayin watsawa[1].

2. Bayyanar Asibiti da Kalubalen Ganewa

Mpox yana da nau'ikan siffofi na asibiti, tun daga kamuwa da cuta mai rashin alamun cutar zuwa mummunan cututtuka na tsarin jiki. Alamomin da aka fi sani sun haɗa dazazzabi, ciwon kai, lymphadenopathy, myalgia, da gajiyada sauransu.Kurajen halayyar yana tasowa ta hanyarMatakan macular, papular, vesicular, da pustular kafin ɓarkewa, kuma yana iya haɗawa dafuska, gaɓɓai, mucosa na baki, da yankunan da ba a haifa ba.

Duk da cewa yawancin shari'o'in suna iyakance kansu cikin makonni 2-4, sakamako mai tsanani ya fi yiwuwa ga mutanen da ke cikin mawuyacin hali, ciki har dajarirai, mata masu juna biyu, da mutanen da ke da rauni a garkuwar jiki(misali, kamuwa da cutar HIV mai tsanani) [2].

Yawan kamuwa da cututtuka marasa tsari da kuma marasa tsari, gami da wadanda ba su nuna alamun cutar ba, yana haifar da manyan kalubale na ganewar asali. Wannan yana nuna muhimmancinbincike mai matuƙar mahimmanci, takamaiman, da sauri don tallafawa ganowa da wuri da kuma katse hanyoyin watsawa.

3. Rigakafi, Kulawa, da Matsayin Ganewar Cututtuka

Yaɗuwar MPXV tana faruwa ta hanyoyi da dama, ciki har da hulɗa kai tsaye da raunuka ko ruwan jiki, digowar numfashi yayin hulɗa ta kusa da juna na dogon lokaci, yaɗuwar jima'i, gurɓatattun ƙwayoyin cuta, da kuma yaɗuwar a tsaye.

Mahimman matakan kulawa sun haɗa da:

• - Ganowa da kuma killace wadanda suka kamu da cutar cikin gaggawa
• - Bin diddigin hulɗa da kuma sa ido kan al'umma
• - Sadarwar haɗari da tsoma baki a cikin halayya
• - Allurar rigakafi kafin da kuma bayan kamuwa da cuta

WHO ta jaddada muhimmancin ƙarfafa ƙarfin dakin gwaje-gwaje da kuma amfani da kayan aikikayan aikin bincike masu dacewa waɗanda aka tsara don saitunan kiwon lafiya daban-daban - daga gwaji mai sauri zuwa dandamalin sa ido kan kwayoyin halitta masu tsakiya[1].

4. Gwajin Macro & Micro-Gwaji: Haɗaɗɗun Maganin Bincike da Ƙirƙirar Fasaha ke jagoranta

A kan yanayin da ilimin cututtukan pox ke ci gaba, Macro & Micro-Test ya ƙirƙiro cikakken fayil ɗin bincike mai dandamali da yawa, yana nuna ƙarfi a cikin ƙirar gwaji, injiniyan ƙwayoyin halitta, da aikace-aikacen fassara.

4.1 Gwaje-gwajen Immunochromatographic Mai Sauri: Gwajin Kulawa Mai Sauƙi

Kamfanin yana ba da ganowa cikin sauri, ba tare da kayan aiki ba cikin mintuna 10-20, yana tallafawa gwaje-gwajen da ba a rarraba su ba da kuma gwaje-gwajen manyan sikelin:

• Kayan Gano Maganin Antigen (HWTS-OT079):
  • Sauƙin ɗaukar samfur (ruwa mai kurji/swab na baki, magani)
  • Iyakar ganowa (LoD): 20 pg/mL
  • Faɗaɗar faɗaɗɗen tsari (Class I & II)
  • Babu haɗin kai tare damakamancin hakaƙwayoyin cuta
  • Jimlar kashi yarjejeniya (OPA): 96.4% idan aka kwatanta da gwaje-gwajen ƙara yawan sinadarin nucleic acid (NAATs)
• Kayan Gano Maganin Kariya na IgM/IgG (HWTS-OT145):
  • Sauƙin ɗaukar samfuri (jini gaba ɗaya, jini, jini)
  • Yana gano IgM da IgG don yanke shawara kan matakan kamuwa da cutar pox
  • Ya dace da binciken cututtukan seroepidemiological

An inganta waɗannan gwaje-gwajen don kwanciyar hankali (4–30°C, watanni 24), tare da magance matsalolin dabaru a cikin iyakokin albarkatun ƙasa.

4.2 Ƙarfafa Ƙarfin Isothermal (EPIA): Gano Kwayoyin Halitta Mai Sauri

Kayan gano ƙwayoyin nucleic acid da ke tushen EPIA (HWTS-OT200) yana wakiltar babban ci gaba a cikin saurin gano ƙwayoyin cuta:

• LoD: kwafi 200/mL (wanda aka kwatanta da qPCR)
• Lokaci zuwa tabbatacce: da sauri kamar mintuna 5
• Gwajin da ake buƙata ta hanyar na'urori masu zaman kansu na Easy Amp System sun kunna
• Tsarin Lyophilized wanda ke ba da damar adana zafin jiki a ɗaki
• Aikin asibiti: (PPA: 100%, NPA: 100%, OPA: 100%) (Kappa = 1.000)

Abu mai mahimmanci, gwajin ya nuna babu wani haɗin gwiwa tsakanin ƙwayoyin cuta na orthopox (ƙananan fuka, allurar rigakafi, ƙwayar cowpox) ko ƙwayoyin cuta na herpes (HSV, VZV), wanda ke nuna cikakken takamaiman bincike.

4.3 Hasken haske qPCR: Ganowar da WHO ta amince da ita sosai

Fayil ɗin PCR na haske na Macro & Micro-Test ya nuna yadda yake bin ƙa'idodin ƙasashen duniya da kuma fahimtar ƙa'idodi:

• HWTS-OT071 (wanda aka jera a cikin jerin sunayen WHO a cikin EU):
  • Tsarin manufa guda biyu wanda ke tabbatar da ƙarfi mai girma
  • LoD: kwafi 200/mL
  • Samfurin samfur mai sauƙin ɗauka na ruwa mai kurji, swab makogwaro da kuma serum
  • Babban takamaiman bayani ba tare da amsawar giciye tare dasƙwayoyin cuta na mallpox, ƙwayoyin cuta na vaccinia, ƙwayoyin cuta na cowpox, ƙwayoyin cuta na mousepox, ƙwayoyin cuta na herpes simplex, ƙwayoyin cuta na varicella-zoster, da kuma kwayoyin halittar ɗan adam, da sauransu.
  • Aikin asibiti: PPA 100%, NPA 99.40%, OPA 99.64% idan aka kwatanta da jerin gwano
• Kit ɗin qPCR busasshe (HWTS-OT078):
  
  • Yana kawar da dogaro da sarkar sanyi yayin da yake ci gaba da aiki
  • Kayan Gano Cututtukan Orthopox na Duniya (HWTS-OT072):
    • Gano ƙwayoyin cuta guda huɗu na orthopox na ɗan adam a lokaci guda(An haɗa da Mpox)
    • LoD: kwafi 200/mL
    • Babban takamaiman bayani ba tare da amsawar giciye tare da irin waɗannan ƙwayoyin cuta ba
    • Rage haɗarin kamuwa da cutar da ba daidai ba kuma yana ƙara haɓaka ganewar bambance-bambance
    • Kwayar cutar MonkeypoxKayan Rubutawa (HWTS-OT201):
      • Yana ba da damar bambancewa tsakanin Clade I da Clade II
      • LoD: kwafi 200/mL
      • Yana da mahimmanci don bin diddigin cututtuka da kuma binciken barkewar cutar

  4.4 Tsarin Tsarin Halittar Halitta: Taimakawa Kula da Kwayoyin Halitta da Bin Diddigin Bambancin Halitta

  Gwajin Macro & Micro-Gwajin ya ƙara nuna ƙwarewa mai zurfi a cikin kwayoyin halittar pathogen ta hanyar hanyoyin samar da jerin kwayoyin halittar gaba ɗaya:

  • BiripoxKit ɗin Kwayoyin Halitta na Duniya na Kwayar cuta (NGS-PCR da yawa) (HWTS-TW0042):
    • Lokacin dawowa: awanni 6-8
    • ≥98% rufewar kwayoyin halitta (Ct ≤32)
    • Daidaituwa mai sassauci tare da mahara2^nd da kuma 3^rd tsaradandamalin jerin abubuwa(ONT, Qi Carbon, Salus, Illumina, MGI…)
    • Mai matuƙar tasiriBiripoxƘwayar cuta Gano Kwayoyin Halitta GabaɗayaKayan aiki (Illumina/MGI) (HWTS-TW0041/0043):
      • Matsakin ganowa: Ct ≤35
      • Tsarin firam mai yawan yawa (1,448)nau'i-nau'i na 200bpamplicons)
      • An tabbatar da shi tare da samfuran asibiti sama da 400
      • Fdacewa mai sauƙin karantawa da yawa2^nd tsaradandamalin jerin abubuwa(Qi Carbon, Salus, Illumina, MGI…)

   
  

  Kididdigar Asibiti na Tsarin Tsarin Kwayoyin Halittar Mpox

  

  Bayanin Tsarin Tsarin Kwayoyin Halitta na Mpox Virus

  Waɗannan kayan aikin Mpox WGS suna tallafawa ilimin cututtukan kwayoyin halitta masu inganci, gami da bin diddigin maye gurbi, taswirar watsawa, da kuma nazarin juyin halitta daban-daban.

  5. Kammalawa: Inganta Gudanar da Mpox na Duniya Ta Hanyar Ingantaccen Kimiyya

  Ci gaba da yaɗuwar kwayoyin halitta na MPXV a duniya da kuma bambancin kwayoyin halitta yana buƙatar dabarun bincike masu matakai da yawa waɗanda suka haɗa da gwaje-gwajen sauri, gwajin ƙwayoyin halitta masu tabbatarwa, da kuma sa ido kan kwayoyin halitta.

  Cikakken tsarin bincike na Macro & Micro-Test yana nuna ingantaccen ƙirƙira na kimiyya a fannoni daban-daban na fasaha, gami da gwaje-gwajen rigakafi, haɓaka ƙarfin isothermal, PCR na lokaci-lokaci, da kuma jerin tsararraki na gaba. Waɗannan mafita ba wai kawai suna magance buƙatun asibiti da na lafiyar jama'a na yanzu ba, har ma suna daidaita da ƙa'idodin ƙasa da ƙasa da kuma yanayin bincike mai tasowa.

  Ta hanyar ba da damar ganowa cikin sauri, tantancewa daidai, da kuma sa ido kan kwayoyin halitta a ainihin lokaci, kamfanin yana taka muhimmiyar rawa wajen ƙarfafa shiri da kuma mayar da martani ga mpox da sauran cututtukan da ke tasowa a duniya.

  Nassoshi:

  [1] WHO. Rahoton Yanayin Duniya na Mpox. Maris, 2026, Geneva: Hukumar Lafiya ta Duniya; 2026
  [2] WHO. Gudanar da Asibiti da Rigakafin Kamuwa da Cututtuka ga Mpox. Mayu 2025, Geneva: Hukumar Lafiya ta Duniya; 2025